1 Min Read
March 27 (Reuters) - ProQR Therapeutics NV:
* ProQR appoints David M. Rodman, MD as chief development strategy officer Source text for Eikon: Further company coverage:
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2017 Reuters. All Rights Reserved.